/Idexx%20Laboratories%2C%20Inc_%20phone%20and%20logo-%20by%20T_Schneider%20via%20Shutterstock.jpg)
IDEXX Laboratories, Inc. (IDXX), valued at a market cap of almost $35 billion, develops, manufactures, and distributes products mainly for the companion animal veterinary, livestock and poultry, dairy, and water testing markets. The Westbrook, Maine-based company also sells a series of portable electrolytes and blood gas analyzers for the human point-of-care medical diagnostics market. It is expected to announce its fiscal Q4 earnings results before the market opens on Monday, Feb. 3.
Ahead of this event, analysts project the pet healthcare company to report a profit of $2.40 per share, up 3.5% from $2.32 per share in the year-ago quarter. The company has surpassed Wall Street's bottom-line estimates in three of the last four quarters while missing on one another occasion.